2019
DOI: 10.1080/02656736.2019.1575482
|View full text |Cite
|
Sign up to set email alerts
|

Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group

Abstract: Mauri (2019) Minimallyinvasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group,

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
182
0
6

Year Published

2019
2019
2024
2024

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 161 publications
(199 citation statements)
references
References 70 publications
3
182
0
6
Order By: Relevance
“…Various image-guided ablation techniques, with different modes of action, are available for the management of symptomatic benign thyroid nodules [24,25]. EA for cystic, and TA techniques for solid lesions, have been thoroughly evaluated and considered both safe and effective when used by operators with specific expertise [26]. In the light of the above, and in order to better characterize the diffusion of MIT procedures into current European clinical practice, the ETA conducted a survey among its members.…”
Section: Discussionmentioning
confidence: 99%
“…Various image-guided ablation techniques, with different modes of action, are available for the management of symptomatic benign thyroid nodules [24,25]. EA for cystic, and TA techniques for solid lesions, have been thoroughly evaluated and considered both safe and effective when used by operators with specific expertise [26]. In the light of the above, and in order to better characterize the diffusion of MIT procedures into current European clinical practice, the ETA conducted a survey among its members.…”
Section: Discussionmentioning
confidence: 99%
“…These non-surgical techniques are implemented over large parts of Europe and the Far East and are used in several thyroid centers. Despite this, there is little guidance, besides a few national consensus papers [9][10][11][12], on the appropriate use of TA in clinical practice. While US-guided diagnostic procedures are widely employed by European endocrinologists, routine use of US-guided therapeutic procedures is still limited to specialized thyroid centers [13].…”
Section: Scope Of the Documentmentioning
confidence: 99%
“…TA should never be performed on nodules with high-risk US features (EU-TI-RADS Class 5) due to their considerable risk of harboring malignancy [15,29]. Since medullary thyroid cancer may not display suspicious sonographic features or unambiguous cytological findings, a single calcitonin determina-tion should be considered, together with TSH, in the initial biochemical evaluation [2,11].…”
Section: Patient Eligibility and Preparationmentioning
confidence: 99%
“…Side effects, complications, tolerability and satisfaction were documented. The terminology and reporting criteria followed consensus guidelines [19,[21][22][23][24].…”
Section: Adverse Eventsmentioning
confidence: 99%